Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research
- PMID: 20889248
- PMCID: PMC2997909
- DOI: 10.1016/j.cpr.2010.09.002
Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research
Abstract
The DSM-5 formulation presents an opportunity to refine the negative symptom assessments that are crucial for a schizophrenia diagnosis. This review traces the history of negative symptom constructs in neuropsychiatry from their earliest conceptualizations in the 19th century. It presents the relevant literature for distinguishing between different types of negative symptoms. Although a National Institute of Mental Health consensus initiative proposed that there are five separate negative symptom domains, our review of the individual items demonstrates no more than three negative symptom domains. Indeed, numerous factor analyses of separate negative symptom scales routinely identify only two domains: 1) expressive deficits, which include affective, linguistic and paralinguistic expressions, and 2) avolition for daily life and social activities. We propose that a focus on expressive deficits and avolition will be of optimum utility for diagnosis, treatment-considerations, and research purposes compared to other negative symptom constructs. We recommend that these two domains should be assessed as separate dimensions in the DSM-5 criteria.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Negative symptoms, past and present: a historical perspective and moving to DSM-5.Eur Neuropsychopharmacol. 2014 May;24(5):710-24. doi: 10.1016/j.euroneuro.2013.10.018. Epub 2013 Nov 21. Eur Neuropsychopharmacol. 2014. PMID: 24314851
-
Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts.J Psychiatr Res. 2013 Jun;47(6):718-25. doi: 10.1016/j.jpsychires.2013.01.024. Epub 2013 Mar 6. J Psychiatr Res. 2013. PMID: 23472837
-
Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning.Eur Arch Psychiatry Clin Neurosci. 2023 Dec;273(8):1715-1724. doi: 10.1007/s00406-022-01507-4. Epub 2023 Jan 12. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 36633673
-
Negative symptoms in schizophrenia: avolition and Occam's razor.Schizophr Bull. 2010 Mar;36(2):359-69. doi: 10.1093/schbul/sbn094. Epub 2008 Jul 21. Schizophr Bull. 2010. PMID: 18644851 Free PMC article. Review.
-
[The clinic of apathy in schizophrenia: a critical review of the issue].Encephale. 2014 Jun;40(3):231-9. doi: 10.1016/j.encep.2013.05.002. Epub 2013 Aug 16. Encephale. 2014. PMID: 23958346 Review. French.
Cited by
-
Acute N-methyl-D-aspartate receptor hypofunction induced by MK801 evokes sex-specific changes in behaviors observed in open-field testing in adult male and proestrus female rats.Neuroscience. 2013 Jan 3;228:200-14. doi: 10.1016/j.neuroscience.2012.10.026. Epub 2012 Oct 22. Neuroscience. 2013. PMID: 23085219 Free PMC article.
-
A Two-Factor Model Better Explains Heterogeneity in Negative Symptoms: Evidence from the Positive and Negative Syndrome Scale.Front Psychol. 2016 May 12;7:707. doi: 10.3389/fpsyg.2016.00707. eCollection 2016. Front Psychol. 2016. PMID: 27242619 Free PMC article.
-
The Latent Structure of Negative Symptoms in Schizophrenia.JAMA Psychiatry. 2018 Dec 1;75(12):1271-1279. doi: 10.1001/jamapsychiatry.2018.2475. JAMA Psychiatry. 2018. PMID: 30208377 Free PMC article.
-
Compensatory Cognitive Training for psychosis: Effects on negative symptom subdomains.Schizophr Res. 2019 Feb;204:397-400. doi: 10.1016/j.schres.2018.09.024. Epub 2018 Oct 4. Schizophr Res. 2019. PMID: 30293693 Free PMC article. Clinical Trial.
-
Intranasal Oxytocin for Negative Symptoms of Schizophrenia: Systematic Review, Meta-Analysis, and Dose-Response Meta-Analysis of Randomized Controlled Trials.Int J Neuropsychopharmacol. 2021 Aug 20;24(8):601-614. doi: 10.1093/ijnp/pyab020. Int J Neuropsychopharmacol. 2021. PMID: 33890987 Free PMC article.
References
-
- Abrams R, Taylor MA. A rating scale for emotional blunting. Am J Psychiatry. 1978;135:226–229. - PubMed
-
- Alpert M, Pouget ER, Sison C, Yahia M, Allan E. Clinical and acoustic measures of the negative syndrome. Psychopharmacol Bull. 1995;31:321–326. - PubMed
-
- Alpert M, Shaw RJ, Pouget ER, Lim KO. A comparison of clinical ratings with vocal acoustic measures of flat affect and alogia. J Psychiatr Res. 2002;36:347–353. - PubMed
-
- Alphs LD, Summerfelt A, Lann H, Muller RJ. The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia. Psychopharmacol Bull. 1989;25:159–163. - PubMed
-
- Andreasen NC. Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry. 1982;39:784–788. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical